marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Akebia Therapeutics Cash Flow 2011-2024 | AKBA
Annual Cash Flow Akebia Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-23.4 M | -73.2 M | -253 M | -110 M | -257 M | -97.5 M | -56.2 M | 57.9 M | - | - | - | - | - |
Depreciation & Amortization |
1.58 M | 1.65 M | 1.93 M | 2.08 M | 2.24 M | 899 K | 617 K | 296 K | 96 K | 49 K | 1 K | - | - |
Accounts Payables |
14.6 M | 18 M | 33.6 M | 41.3 M | 39.2 M | 42.8 M | 7 M | 2.04 M | 2.31 M | 2.02 M | - | - | - |
Accounts Receivables |
39.3 M | 40.3 M | 51.6 M | 26.9 M | 38.9 M | 16.7 M | 34.2 M | - | - | 48 K | - | - | - |
Total Inventories |
15.7 M | 21.6 M | 36.6 M | 61 M | 116 M | 114 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Akebia Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | - | -17.5 M | - | -18.5 M | - | -21.6 M | - | -190 M | - | -70.7 M | - | -79.6 M | -52.4 M | -89.6 M | - | -165 M | -176 M | -138 M | - | -23.8 M | -11.3 M | -20.3 M | - | -39.8 M | 14.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
9 M | 9 M | - | 9 M | 9 M | 9.01 M | - | 9 M | 9 M | 9.01 M | - | 9 M | 9 M | 9.01 M | - | 500 K | 500 K | 525 K | - | 600 K | 600 K | 439 K | - | 638 K | 413 K | 199 K | - | 420 K | 253 K | 135 K | - | 172 K | 78 K | 32 K | - | 85 K | 50 K | 19 K | - | 13 K | 12 K | 8 K | - | 26 | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
13.5 M | 10.1 M | 14.6 M | 9.04 M | 11.8 M | 12.6 M | 18 M | 19.7 M | - | 19.5 M | 33.6 M | 28.8 M | 42 M | 30.5 M | 41.3 M | 41.3 M | 41.3 M | 41.3 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 42.8 M | 42.8 M | 42.8 M | 42.8 M | 7 M | 7 M | 7 M | 7 M | 2.04 M | 2.04 M | 2.04 M | 2.04 M | 2.31 M | 2.31 M | 2.31 M | 2.31 M | 2.02 M | 2.02 M | 2.02 M | 2.02 M | 714 K | 714 K | 714 K | 714 K | - | - | - | - | - | - | - | - |
Accounts Receivables |
32.2 M | 29.8 M | 39.3 M | 22.6 M | 19.6 M | 17.8 M | 40.3 M | 23.1 M | 82 M | 64.6 M | 50.9 M | 49.7 M | 35 M | 35.2 M | 26.9 M | 26.9 M | 26.9 M | 26.9 M | 38.9 M | 38.9 M | 38.9 M | 38.9 M | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 34.2 M | 34.2 M | 34.2 M | 34.2 M | 33.8 M | - | - | - | - | 14 K | 48 K | 74 K | 48 K | 57 K | 48 K | 48 K | 135 K | 135 K | 135 K | 135 K | - | - | - | - | - | - | - | - |
Total Inventories |
20.5 M | 23.9 M | 15.7 M | 18.4 M | 20.9 M | 20.6 M | 21.6 M | 40 M | 40.2 M | 39.4 M | 38.2 M | 33.7 M | 37.9 M | 44.8 M | 61 M | 61 M | 61 M | 61 M | 116 M | 116 M | 116 M | 116 M | 114 M | 114 M | 114 M | 114 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency